NuMedii company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

numedii.com

Stage

Series A | Alive

Total Raised

$3.5M

Last Raised

$3.5M | 9 yrs ago

About NuMedii

NuMedii discovers and de-risks effective new drugs by translating its predictive Big Data technology into therapies with a higher probability of therapeutic success. The company's Big Data technology consists of billions of data points of ever-increasing amounts of comprehensive disease, pharmacological and clinical data. NuMedii integrates these data with network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The company has successfully validated its Big Data technology as six of six drug candidates have demonstrated preclinical activity for the predicted new indication. NuMedii will partner with pharmaceutical companies for the development and commercialization of its therapeutic candidates.

NuMedii Headquarter Location

PO Box 7381

Menlo Park, California, 94026,

United States

650-918-6363

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing NuMedii

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NuMedii is included in 3 Expert Collections, including Clinical Trials Tech.

C

Clinical Trials Tech

326 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

A

Artificial Intelligence

8,718 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

B

Biopharma Tech

6,405 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

NuMedii Patents

NuMedii has filed 2 patents.

The 3 most popular patent topics include:

  • Lung disorders
  • Occupational diseases
  • Pneumonia
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/4/2014

Beta blockers, Inflammations, Gastrointestinal tract disorders, Amines, Autoimmune diseases

Application

Application Date

4/4/2014

Grant Date

Title

Related Topics

Beta blockers, Inflammations, Gastrointestinal tract disorders, Amines, Autoimmune diseases

Status

Application

Latest NuMedii News

Global AI for Drug Discovery Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025: Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc., Envisagenics

Mar 11, 2021

Thursday, 11 Mar 2021 05:19 pm Global AI for Drug Discovery Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025: Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc., Envisagenics Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity. By SMN Bureau   Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity. A Latest report published by The Insight Partners named “ AI for Drug Discovery Market ” presents currents and future opportunities, growth scenario, market share and AI for Drug Discovery industry size. The AI for Drug Discovery Report is an excellent source that provides present as well as future analysis of the Industry (both technical & financial) in detail. In addition, the competitive analysis provided in the report gives a superficial idea about the key strategies used by the key players in the market which help them grown their market status. This research study has considered key break downs in the Industry and competing factors which is valuable to take your business to the innovative level. Get Free Sample Brochure (including full TOC, Tables and Figures: https://www.theinsightpartners.com/sample/TIPRE00004177/?source=smartmarketnews-10408 This report can be customized based on the client-specific requirements and stated development. The AI for Drug Discovery Market awareness and growth status are reflected in the report. In-depth insights into the emerging market manufacturers, a SWOT analysis will improve the forecast market growth for profitable business ideas. The AI for Drug Discovery Industry overview, recent developments, manufacturing base, consumption details are scrutinized deeply. Competitive Landscape of Global AI for Drug Discovery Market: Atomwise, Inc. Global AI for Drug Discovery Market Segmentation and Regional Analysis: The AI for Drug Discovery Market share for each type and application is for the year 2020. The revenue share, sales price, upstream raw material suppliers, downstream buyers, and pricing array of AI for Drug Discovery Market is instructed. The dynamic changes in AI for Drug Discovery Industry, technological advancements, mergers & acquisitions are stated. The complete AI for Drug Discovery business profile, products & services overview, geographical presence, import-export details and Market share, gross margin, etc. is summarized in this study. Note: If you have any special requirements, please let us know and we will offer you the report as you want. Global AI for Drug Discovery Market Segment By Region: North America (United States, Canada, Mexico, Europe, Germany, UK, France, Italy, Spain, Russia, Others) Asia-Pacific (China, Japan, South Korea, Australia, India, Southeast Asia, Others) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Others) South America (Brazil, Argentina, Columbia, Chile, Others) AI for Drug Discovery report can be divided into following 12 segments Segment 1, states the objectives of AI for Drug Discovery market, review, introduction, product description, growth aspects, and industry presence; Segment 2, elaborates the AI for Drug Discovery market based on key players, their market share, sales volume, company profiles, AI for Drug Discovery competitive market scenario and pricing structure from 2015 to 2019; Segment 3, analyzes the AI for Drug Discovery market at a regional level based on sales ratio and market size from 2015 to 2019; Segment 4, 5, 6 and 7, explains the AI for Drug Discovery market at the country level based on product type, applications, revenue analysis; Segment 8 and 9, states the AI for Drug Discovery industry overview during past, present and forecast period from 2020 to 2026; Segment 10 and 11, describes the market status, plans, expected growth based on regions, type and application in detail for a forecast period of 2020-2026; Segment 12, covers the marketing channels, dealers, manufacturers, trader, distributors, consumers of AI for Drug Discovery. About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense. Contact Us: Email: sales@theinsightpartners.com

NuMedii Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NuMedii Rank

  • Where is NuMedii's headquarters?

    NuMedii's headquarters is located at PO Box 7381, Menlo Park.

  • What is NuMedii's latest funding round?

    NuMedii's latest funding round is Series A.

  • How much did NuMedii raise?

    NuMedii raised a total of $3.5M.

  • Who are the investors of NuMedii?

    Investors of NuMedii include Claremont Creek Ventures, Life Science Angels and Lightspeed Venture Partners.

  • Who are NuMedii's competitors?

    Competitors of NuMedii include Terray Therapeutics.

You May Also Like

Atomwise Logo
Atomwise

Atomwise uses deep learning neural networks to help discover new medicines. Atomwise achieves results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, start-ups, and research institutions. It is currently using computational drug design to design drugs against COVID.

Verge Genomics Logo
Verge Genomics

Verge Genomics works to discover drugs for neurodegenerative diseases using computational genomics.

BioLizard Logo
BioLizard

BioLizard is a bioinformatics and AI company that provides multi-omics data analysis, algorithm development, data mining and integration, and pipeline and app development for scientific data needs. It is based in Ghent, Belgium.

Insilico Medicine Logo
Insilico Medicine

Insilico Medicine develops a range of generative adversarial networks (GANs) and reinforcement learning approaches to identify protein targets, generate molecular structures with specified properties, and generate synthetic data. The company provides pharmaceutical and biotechnology companies with artificial intelligence solutions that transform the way innovative medicines and treatments are discovered and accelerate research and development. The company was founded in 2014 and is based in Hong Kong.

T
Terray Therapeutics

Terray Therapeutics is a biotechnology company. The company has developed a novel screening and optimization platform (tArray) to develop invent treatments for intractable causes of human disease. The company is headquartered in Pasadena, California.

Numerate Logo
Numerate

Numerate is a privately held biotechnology company that applies machine-learning algorithms, at cloud scale, to overcome major challenges in small molecule drug discovery. Numerate's drug design platform combines advances in computer science and statistics with traditional medicinal chemistry approaches to address, in parallel, the factors that determine the success and failure of a drug candidate. Numerate is using this platform to develop a pipeline of drug programs in the cardiovascular, metabolic and neurodegenerative disease areas, focused on targets not typically addressed by computer-aided drug discovery.On September 25, 2020, Numerate was acquired by Valo Health. The terms of the transaction were not disclosed.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.